)
JD Health International (6618) investor relations material
JD Health International H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue grew 26.3% year-over-year to RMB 73.4 billion, with non-IFRS profit up 36.3% to RMB 6.5 billion and a record 8.9% non-IFRS profit margin, marking the highest profit margin since IPO.
Maintained revenue growth above 20% for four consecutive quarters, reinforcing market leadership in China's healthcare sector and online pharmaceutical supply chain.
Expanded partnerships with pharmaceutical companies, launched over 100 new drugs, and deepened AI-powered healthcare service capabilities, including AI health assistants and hospital-grade home testing.
Enhanced omnichannel supply chain, integrated online/offline services, and broadened product offerings in health supplements and medical devices.
Annual active users reached 217.7 million, with significant expansion in digital health solutions and user engagement.
Financial highlights
Full-year 2025 revenue reached RMB 73.4 billion, up 26.3% year-over-year; Q4 revenue was RMB 21 billion, up 27.4%.
Non-IFRS profit for 2025 was RMB 6.5 billion, up 36.3% year-over-year, with a margin of 8.9%.
Gross profit increased 36.7% to RMB 18.2 billion, with gross margin rising to 24.8% from 22.9%.
Direct sales revenue reached RMB 16.9 billion, up 24.8% year-over-year, accounting for 82.9% of total revenue.
Service revenue was RMB 12.6 billion, up 34.1% year-over-year, accounting for 17.1% of total revenue.
Outlook and guidance
Significant room for growth remains in the RMB 3-4 trillion healthcare market, with plans to deepen penetration and expand user base.
Focus on expanding product portfolio, especially new and specialty drugs, health supplements, and AI-powered medical devices.
Continued investment in AI technologies and digital health solutions to drive future growth and operational efficiency.
Plans to further strengthen supply chain and deepen collaborations with brands and partners in 2026.
No plans for large-scale M&A; offline pharmacy expansion will be gradual and strategic.
- Net profit jumped 30.2% on 4.6% revenue growth, led by digital health and strong cash position.6618
H1 20242 Feb 2026 - Net profit nearly doubled in 2024 as digital and AI healthcare services expanded.6618
H2 202431 Dec 2025 - Revenue and profit surged, driven by AI innovation and omnichannel healthcare expansion.6618
H1 202523 Nov 2025
Next JD Health International earnings date
Next JD Health International earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)